Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s255, 2023. DOI: 10.25251/skin.7.supp.255. Disponível em: https://skin.dermsquared.com/skin/article/view/2443. Acesso em: 25 jun. 2025.